MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Glabellar tap predicts dopamine transporter deficiency in parkinsonism

S. Nuuttila, J. Joutsa, M. Eklund, E. Jaakkola, E. Mäkinen, T. Noponen, T. Ihalainen, F. Scheperjans, V. Kaasinen (Turku, Finland)

Meeting: 2019 International Congress

Abstract Number: 1001

Keywords: Dopamine, Nigrostriatal dopaminergic synapse deficiency, Parkinsonism

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: The objective of this study was to investigate the association between glabellar tap findings with nigrostriatal dopamine function in patients with unclear parkinsonism.

Background: Striatal DAT deficiency is a hallmark of neurodegenerative parkinsonism syndromes. Diagnostics of these syndromes is currently mainly based on clinical characteristics. Brain presynaptic dopamine imaging can be used to differentiate unclear cases by evaluating striatal dopamine deficit. However, imaging is not always available, and it is associated with costs and ionizing radiation. Testing primitive reflexes, such as glabellar tap test, can be helpful in differential diagnostics but the value of these tests and their association with brain dopamine deficit are not well characterized. The purpose of this study was to investigate the association between glabellar tap findings with nigrostriatal dopamine function in patients with unclear parkinsonism.

Method: In this cross-sectional study, we performed glabellar tap on 327 patients with unclear parkinsonism immediately prior to diagnostic dopamine transporter (DAT) [I-123] FP-CIT SPECT imaging. Specific putamen DAT binding was used to measure presynaptic nigrostriatal dopamine function. Putamen binding was compared between patients with abnormal (>3 taps before habituation) and normal (max. 3 taps) glabellar tap reflex using the two-sample t-test. Furthermore, putamen binding was correlated with glabellar tap results using Pearson’s correlation coefficient.

Results: Putamen DAT binding was lower in the abnormal compared to normal glabellar tap group [mean (SD) 2.04 (0.81) vs. 2.54 (0.79), p<0.001]. The result remained highly significant when controlled for age and gender (p=0.001). In addition, there was a negative correlation between DAT binding and glabellar tap score (r=-0.30, p<0.001), which again remained significant after adjusting for age and gender (r=-0.30, p<0.001).

Conclusion: Abnormal glabellar tap reflex is associated with lower levels of presynaptic striatal DAT binding in patients with unclear parkinsonism. This finding suggests that glabellar tap could be a useful clinical test for differential diagnostics in this population and possibly reduce the need for molecular brain imaging.

To cite this abstract in AMA style:

S. Nuuttila, J. Joutsa, M. Eklund, E. Jaakkola, E. Mäkinen, T. Noponen, T. Ihalainen, F. Scheperjans, V. Kaasinen. Glabellar tap predicts dopamine transporter deficiency in parkinsonism [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/glabellar-tap-predicts-dopamine-transporter-deficiency-in-parkinsonism/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/glabellar-tap-predicts-dopamine-transporter-deficiency-in-parkinsonism/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley